drugset / Trial / NCT01514357
Nesiritide in Resistant Hypertension
Phase 1/2
Terminated
12 enrolled
John C Burnett
National Center for Research Resources (NCRR) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Hypothesis: If the use of B-type natriuretic peptide (BNP) is proven to be effective in controlling high blood pressure, it may lead to a reduction of standard therapy and improved cardiovascular and kidney protection.
Timeline
- Start
- 2012-04
- Primary completion
- 2014-07
- Completion
- 2014-07
Outcome
Outcome not reported
Stopped (Business): “Original PI left the institution, and lack of funding.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nesiritide | Protein / enzyme biologic | 5 ug/kg | Subcutaneous |